NCT01097967View on ClinicalTrials.gov

Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy

PHASE4UnknownINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
TIAIschemic Stroke
Interventions
OTHER

CPAP

Trial Locations (5)

Unknown

University Hospital Münster, Münster

I-20162

Dipartimento Neuroscienze, Ospedale Niguarda, Milan

CH-3010

Inselspital, Universitätsklinik für Pneumologie, Bern

CH-6500

Ospedale San Giovanni, Bellinzona

CH-6900

Neurocenter of Southern Switzerland, Ospedale Civico, Lugano

Sponsors

Collaborators (2)

ResMed
Philips Respironics
All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

Schweizerische Herzstiftung

OTHER

collaborator

ResMed

INDUSTRY

collaborator

Philips Respironics

INDUSTRY

lead

Prof. Claudio Bassetti

OTHER_GOV

NCT01097967 - Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy | Biotech Hunter | Biotech Hunter